ACL Graft Choice Risk Factors ACL-RSI Calculator (Return to Sport Readiness)AHA Pre-Participation Screening AOFAS Ankle-Hindfoot Scale ASES Elbow Score ASES Shoulder Score Acute:Chronic Workload Ratio (ACWR)Altitude Gain Guidelines Ankle Syndesmosis (High Ankle Sprain)Athlete's Heart vs HCM Beighton Score (Joint Hypermobility)Borg CR-10 Scale Borg RPE Scale (6–20)Brighton Criteria (BJHS)Buffalo Concussion Treadmill Test (BCTT)Child SCAT6 (Age 8–12)Commotio Cordis Protocol Cumberland Ankle Instability Tool (CAIT)DASH (UE Disability Index)Doha Groin Agreement ESC HCM SCD Risk Score ESC Pre-Participation Screening Energy Availability Calculator FAI Syndrome (Warwick)FAOS (Foot and Ankle Outcome Score)Fear-Avoidance Beliefs Questionnaire (FABQ)Female Athlete Triad Risk Foot Posture Index (FPI-6)Foot and Ankle Ability Measure (FAAM)Functional Movement Screen (FMS)Graduated Return-to-Play (GRTP) Protocol HAGOS (Hip and Groin Outcome Score)Hamstring Asymmetry Index Heat Index (Apparent Temp)Hip Outcome Score (HOS)Hooper Index (Athlete Wellness)I-PRRS (Psychological Readiness)IKDC (Objective Examination)IKDC (Subjective Knee Evaluation)Injury Severity KJOC Shoulder & Elbow Score KOOS (Knee Outcome Score)KOOS-PS (Physical Function Short Form)Kujala (Anterior Knee Pain Scale)LEAF-Q (LEA Screening)Lake Louise AMS Score Limb Symmetry Index (LSI)Little League Elbow Grading Lysholm Knee Score Marx Activity Rating Scale (MARS)Mayo Elbow Performance Score (MEPS)Modified Schober Test NEXUS C-Spine Criteria Neck Disability Index (NDI)One-Rep Max Estimator Osgood-Schlatter Severity Oswestry Disability Index (ODI)Ottawa Knee Rules Oxford Elbow Score Oxford Shoulder Score PAR-Q+ Readiness Questionnaire PARS-3 Youth Readiness Patellar Instability Severity Score Pitch Smart Guidelines (USA Baseball)Pittsburgh Knee Rules Post-Concussion Symptom Scale (PCSS)QuickDASH (Shoulder & UE)RED-S CAT (Clinical Assessment)Re-injury Anxiety Inventory (RIAI)Relative Age Effect (RAE)Return-to-Play Battery SANE Score (Single Assessment)SCAT6 (Sport Concussion Assessment Tool 6)SCOAT6 (Sub-acute and Office Follow-up)SEAQ-I Appetite Questionnaire STarT Back Screening Tool Session RPE (Internal Load)Sever's Disease Activity Single-Leg Hop Test Battery Standardized Assessment of Concussion (SAC)Steroid Equivalence Calculator Stinger / Burner Grading Sweat Rate and Rehydration TSK-11 (Tampa Scale for Kinesiophobia)TUE Criteria Checklist Tanner Stage Assessment Tegner Activity Scale (TAS)Training Monotony and Strain UCL Injury Risk (Medial Elbow)VISA-A (Achilles Tendinopathy)VISA-P Scale (Patellar Tendinopathy)VO2 Max VOMS (Vestibular/Ocular-Motor Screening)WADA Prohibited List Checker WBGT (Wet Bulb Globe Temp)WORC (Rotator Cuff Index)WOSI (Shoulder Instability Index)Wilks Score (Relative Strength)Wind Chill Index hEDS Diagnostic Criteria (2017)iHOT-33 (International Hip Outcome Tool)

Recent Journal Updates

British J Clinical PharmacologyJun 26, 2026

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

British J HaematologyJun 18, 2026

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

Clinical Pharmacology TherapeuticsJun 5, 2026

Correction to “A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End‐Stage Kidney Disease on Hemodialysis”

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

Tanner Stage Assessment

Tanner Staging (Adolescent Growth)

Stage 1

Pre-pubertal

Tanner Staging is used in sports medicine to estimate maturation status, which is more predictive of injury risk (e.g., apophysitis) and performance than chronological age alone. Stage 3–4 often coincides with the Peak Height Velocity (PHV) "danger zone" for growth-related injuries.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Pre-participation physical evaluation (PPE) for adolescent athletes to determine biological maturity relative to chronological age.

Monitoring growth and pubertal development in young athletes to tailor training loads and prevent overuse injuries.

Screening for delayed or precocious puberty in athletes presenting with growth concerns or performance plateaus.

Stratifying injury risk in pediatric sports medicine, particularly for growth plate injuries and apophysitis.

Assessing readiness for sport specialization and high-intensity training programs.

Evaluating hormonal influences on bone density, muscle mass, and metabolic function in adolescent athletes.

Key Indication - Maturity Offset and Injury Risk Stratification

Tanner staging is essential for identifying the peak height velocity (PHV) period, during which adolescents are at highest risk for growth-related injuries such as Osgood-Schlatter disease, Sever disease, and stress fractures. The International Olympic Committee (IOC) and American Academy of Pediatrics (AAP) recommend maturity assessment as part of the PPE to guide safe sport participation and training progression.

When Not to Use / Contraindications

Do not use as a sole determinant of athletic ability or performance potential.

Avoid in children with known endocrine disorders (e.g., hypogonadism, precocious puberty) without specialist interpretation.

Not suitable for post-pubertal adults (Tanner Stage V) as the scale plateaus.

Caution in patients with genital anomalies or those who have undergone gender-affirming hormone therapy; use alternative maturity assessments.

Self-assessment by patients may be unreliable; clinician training is required for accurate staging.

Last Comprehensive Review: 2026

Recent Journal Updates

British J Clinical PharmacologyJun 26, 2026

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

British J HaematologyJun 18, 2026

Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

Clinical Pharmacology TherapeuticsJun 5, 2026

Correction to “A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End‐Stage Kidney Disease on Hemodialysis”

Clinical Context

We think this might be relevant to the clinical guidance for Tanner Stage Assessment.

Tanner Stage Assessment

Tanner Staging (Adolescent Growth)

Stage 1

Pre-pubertal

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Pre-participation physical evaluation (PPE) for adolescent athletes to determine biological maturity relative to chronological age.

Monitoring growth and pubertal development in young athletes to tailor training loads and prevent overuse injuries.

Screening for delayed or precocious puberty in athletes presenting with growth concerns or performance plateaus.

Stratifying injury risk in pediatric sports medicine, particularly for growth plate injuries and apophysitis.

Assessing readiness for sport specialization and high-intensity training programs.

Evaluating hormonal influences on bone density, muscle mass, and metabolic function in adolescent athletes.

Key Indication - Maturity Offset and Injury Risk Stratification

When Not to Use / Contraindications

Do not use as a sole determinant of athletic ability or performance potential.

Avoid in children with known endocrine disorders (e.g., hypogonadism, precocious puberty) without specialist interpretation.

Not suitable for post-pubertal adults (Tanner Stage V) as the scale plateaus.

Caution in patients with genital anomalies or those who have undergone gender-affirming hormone therapy; use alternative maturity assessments.

Self-assessment by patients may be unreliable; clinician training is required for accurate staging.

Last Comprehensive Review: 2026

Recent Journal Updates

Tanner Stage Assessment

Stage 1

Pre-pubertal

Early Puberty

Mid Puberty

Late Puberty

Adult / Post-pubertal

When to Use

When to Use

Key Indication - Maturity Offset and Injury Risk Stratification

When Not to Use / Contraindications

Recent Journal Updates

Tanner Stage Assessment

Stage 1

Pre-pubertal

Early Puberty

Mid Puberty

Late Puberty

Adult / Post-pubertal

When to Use

When to Use

Key Indication - Maturity Offset and Injury Risk Stratification

When Not to Use / Contraindications